Dual Antitumor and Antiangiogenic Activity of Organoplatinum(II) Complexes-Reference-Cited by-同舟云学术

Dual Antitumor and Antiangiogenic Activity of Organoplatinum(II) Complexes

Published:2015-01-27 Issue:3 Volume:58 Page:1320-1336
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zamora Ana¹,Pérez Sergio A.¹,Rodríguez Venancio¹,Janiak Christoph²,Yellol Gorakh S.¹,Ruiz José¹

Affiliation:

1. Departamento de Química Inorgánica and Regional Campus of International Excellence “Campus Mare Nostrum“, Universidad de Murcia, and Institute for Bio-Health Research of Murcia (IMIB-Arrixaca), E-30071 Murcia, Spain

2. Institut für Anorganische Chemie und Strukturchemie, Heinrich-Heine-Universität Düsseldorf, Universitätsstrasse 1, D-40225 Düsseldorf, Germany

Funder

Ministerio de Economía y Competitividad

European Commission Directorate-General for Research and Innovation

Fundación Séneca

European Regional Development Fund

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm501662b

Reference64 articles.

1. Cancer Facts & Figures 2013;American Cancer Society:Atlanta, 2013; pp1–60.

2. Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer

3. New perspectives in ovarian cancer treatment

4. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

5. Antiangiogenic Therapies in Epithelial Ovarian Cancer

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in coordination compounds and their potential clinical application in the management of diseases: An up-to-date review;Polyhedron;2023-09

2. Cyclometalated Ru(ii)–NHC complexes with phenanthroline ligands induce apoptosis mediated by mitochondria and endoplasmic reticulum stress in cancer cells;Dalton Transactions;2023

3. Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design;New Journal of Chemistry;2023

4. Pt(ii) and Pt(iv) complexes with a major component of royal jelly as innovative antitumor drug candidates;New Journal of Chemistry;2023

5. Introduction of Fluorine into Antitumor-Active Dinuclear Platinum(II) Complexes Leads to Modulation of In Vivo Antitumor Activity in Mice;Inorganic Chemistry;2022-07-25